Two-quadrant anaesthesia technique reduces pain during vitrectomy

Article

Using two-quadrant sub-Tenon's anaesthesia is more effective at reducing intraoperative and postoperative pain than a single-quadrant technique.

Using two-quadrant sub-Tenon's anaesthesia is more effective at reducing intraoperative and postoperative pain than a single-quadrant technique, states a study in the British Journal of Ophthalmology.

Dr Vip S. Gill et al., Department of Anaesthesia, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK, studied 54 patients undergoing vitrectomy. All patients were equally randomized into two groups.

Group A, the control, were administered a standard 5 ml single inferonasal sub-Tenon injection of 2% lidocaine and 0.5% bupivacaine in a 50:50 mixture. Group B, the study group, received a 5 ml inferonasal and 5 ml superotemporal injection.

Primary outcome measures included amount of intraoperative top-ups needed and the secondary outcome measures included intraoperative and postoperative pain scores, IOP, block onset time, ocular akinesia, eyelid akinesia and chemosis.

In the group V there were no patients requiring an anaesthetic top-up, but in the control group a top-up was needed in 24 patients. In group B block onset was shorter, eyelid akinesia was improved and pain scores were reduced intraoperatively and 0–2 hours (h), 4–6 h, 10–14 h and 20–24 h postoperatively.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.